A multicentre, open-label, extension study, evaluating the safety and tolerability and the efficacy of ADV7103 at long term in distal renal tubular acidosis patients.

Trial Profile

A multicentre, open-label, extension study, evaluating the safety and tolerability and the efficacy of ADV7103 at long term in distal renal tubular acidosis patients.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Potassium bicarbonate/potassium citrate (Primary)
  • Indications Metabolic acidosis; Renal tubular acidosis
  • Focus Adverse reactions
  • Sponsors Advicenne
  • Most Recent Events

    • 05 Jul 2017 According to an Advicenne media release, results from this study are expected in the coming months.
    • 21 Jun 2017 According to an Advicenne media release, data from the study will be presented at the upcoming 50th European Society of Paediatric Nephrology (ESPN) 2017 Annual Meeting.
    • 09 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top